MétaCan
Menu
Back to cohort

Abstract PO081: Systematic Generation of Allogeneic Immune-targeting Modalities for Glioblastoma

2021· article· en· W3126199907 on OpenAlexaff
Sabra K. Salim, Jiarun Wei, V. Dimitrov, Katherine Chen, Chitra Venugopal, Parvez Vora, Jason Moffat, Sheila K. Singh

Bibliographic record

VenueCancer Immunology Research · 2021
Typearticle
Languageen
FieldMedicine
TopicCAR-T cell therapy research
Canadian institutionsUniversity of TorontoMcMaster University
Fundersnot available
KeywordsMedicinePopulationHaematopoiesisImmune systemProgenitor cellChimeric antigen receptorStem cellChemoradiotherapyOncologyImmunotherapyCancer researchCancerImmunologyInternal medicineBiology

Abstract

fetched live from OpenAlex

Abstract Glioblastoma (GBM) is one of the most common brain tumors in adults. Despite a standard-of-care including surgery and chemoradiotherapy, patients only live to a median of 15 months. This may be due to extensive spatiotemporal, intratumoral heterogeneity observed. This is thought to be created by a small population of stem-like cells marked by expression of CD133. CD133 has been shown to correlate with poor patient prognosis, metastases, relapse and worse overall survival in GBM. We thus created an anti-CD133 CAR-T therapy. Our CD133-targeting CAR-T (CART133) has shown great efficacy and in our patient-derived models of GBM. It has also exhibited safety in sparing healthy CD133-expressing cells, particularly, hematopoietic stem and progenitor cells, in our humanized model of hematopoiesis. However, in looking to the clinic, the generation of autologous CAR-Ts may be difficult as it requires sufficient numbers of a patient's own T-cells who may be immunocompromised after first-line therapy. Thus, we propose to generate allogeneic CAR-Ts that target CD133 (AlloCART133) from healthy donor T- cells. AlloCAR-T cells are genetically-edited to abrogate the T-cell receptor (TCR) to avoid graft-versus- host disease, a phenomenon in which immune-mismatch causes donor tissues to attack recipient tissues. These cells can thus be safe for a recipient while also maintaining their anti-tumor activity. AlloCART133 thus presents a clinically-relevant, off-the-shelf therapy for patients with GBM. Citation Format: Sabra K. Salim, Jiarun Wei, Vassil Dimitrov, Katherine Chen, Chitra Venugopal, Parvez Vora, Jason Moffat, Sheila K. Singh. Systematic Generation of Allogeneic Immune-targeting Modalities for Glioblastoma [abstract]. In: Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy; 2020 Oct 19-20. Philadelphia (PA): AACR; Cancer Immunol Res 2021;9(2 Suppl):Abstract nr PO081.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.056
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.130
GPT teacher head0.418
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicCAR-T cell therapy researchFrench-language works237,207